Diagnostic Accuracy of Contrast-Enhanced T2-FLAIR MRI in diagnosing Infective Meningitis taking CSF analysis as gold standard
DOI:
https://doi.org/10.5281/zenodo.22658043Keywords:
contrast-enhanced MRI, T2-FLAIR, infective meningitis, cerebrospinal fluid, diagnostic accuracy, meningeal enhancementAbstract
Objective: To determine the diagnostic accuracy of contrast-enhanced T2 fluid-attenuated inversion recovery (CE-T2-FLAIR) MRI in diagnosing infective meningitis, taking cerebrospinal fluid (CSF) analysis as gold standard.
Methods: In this cross-sectional diagnostic-accuracy study, 142 consecutive adults aged 18-65 years with clinically suspected meningitis underwent 1.5-T brain MRI and CSF analysis. CE-T2-FLAIR was positive when abnormal meningeal enhancement was visible in extra-axial CSF spaces, along superficial brain surfaces, within sulci, or along cranial nerves and cisterns. CSF positivity required pleocytosis of at least 50 cells/µL, protein of at least 40 mg/dL, and a CSF-to-blood glucose ratio of 0.40 or less. Sensitivity, specificity, predictive values, and accuracy were calculated with Wilson 95% confidence intervals.
Results: CSF confirmed infective meningitis in 86/142 participants (60.56%). CE-T2-FLAIR produced 82 true-positive, 10 false-positive, 4 false-negative, and 46 true-negative results. Sensitivity was 95.35% (88.64%-98.18%), specificity 82.14% (70.16%-90.00%), positive predictive value 89.13% (81.14%-93.99%), negative predictive value 92.00% (81.16%-96.85%), and overall accuracy 90.14% (84.13%-94.04%). Accuracy was similar across sex and prespecified age strata.
Conclusion: CE-T2-FLAIR demonstrated high sensitivity and overall diagnostic accuracy for detecting infective meningitis. It can serve as a useful adjunct for recognizing subtle meningeal inflammation and complications, but it should complement rather than replace timely CSF examination and microbiological testing.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in International Journal of Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to share, copy, distribute, and adapt the work for any purpose, even commercially, as long as appropriate credit is given to the original authors. Authors retain the copyright and agree to have their work published under this license, ensuring the broadest possible dissemination and reuse of their research.
For more information or licensing inquiries, contact mossdigital77@gmail.com.



